ARCHIVES

The Varmus Era: Controversy Continues

This article is from The Cancer Letter archive.

Vol. 21 No. 01 | January 6, 1995

Download PDF Visit The Full Archive

Related Articles

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

Fund Squeeze Results In Percentage reductions for Renewed Program Project, Center Core Grants

April 8, 1977

Yarbro Refuses To Seek Core Renewal, Quits Director Post

September 22, 1978

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

August 30, 2013

Stereotactic Body Radiotherapy Could Improve Overall Survival

July 29, 2011

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

October 22, 2010